Asymchem Laboratories (Tianjin) Co., Ltd. (HKG: 6821)
Hong Kong
· Delayed Price · Currency is HKD
49.50
-0.50 (-1.00%)
Jan 28, 2025, 11:50 AM HKT
Asymchem Laboratories (Tianjin) Revenue
Asymchem Laboratories (Tianjin) had revenue of 1.39B CNY in the quarter ending September 30, 2024, a decrease of -19.13%. This brings the company's revenue in the last twelve months to 5.57B, down -36.70% year-over-year. In the year 2023, Asymchem Laboratories (Tianjin) had annual revenue of 7.83B, down -23.70%.
Revenue (ttm)
5.57B CNY
Revenue Growth
-36.70%
P/S Ratio
n/a
Revenue / Employee
569.20K CNY
Employees
9,788
Market Cap
27.57B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.83B | -2.43B | -23.70% |
Jan 1, 2023 | 10.26B | 5.62B | 121.40% |
Dec 31, 2021 | 4.63B | 1.50B | 47.67% |
Dec 31, 2020 | 3.14B | 676.74M | 27.51% |
Dec 31, 2019 | 2.46B | 625.11M | 34.07% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 26.04B |
Hansoh Pharmaceutical Group Company | 13.00B |
JD Health International | 58.84B |
WuXi Biologics | 18.39B |
Sinopharm Group | 634.32B |
Alibaba Health Information Technology | 31.39B |
Akeso | 2.01B |
Innovent Biologics | 8.01B |